W.W. Grainger (GWW) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook ...
Grainger also has harsh words for Woodford, saying this investment, along with his backing for troubled US company Northwest Biotherapeutics, has damaged his reputation. Plenty of good bets left ...